img

Global Drugs to Treat Chronic Kidney Disease Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Drugs to Treat Chronic Kidney Disease Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Drugs to Treat Chronic Kidney Disease Market
Global Drugs to Treat Chronic Kidney Disease market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Drugs to Treat Chronic Kidney Disease industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Drugs to Treat Chronic Kidney Disease key companies include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc and Eli Lilly and Company, etc. Pfizer Inc., Johnson & Johnson, AbbVie Inc. are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Drugs to Treat Chronic Kidney Disease were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Drugs to Treat Chronic Kidney Disease market and estimated to attract more attentions from industry insiders and investors.
Drugs to Treat Chronic Kidney Disease can be divided into Calcimimetics, Vitamin D, Sterols and Potassium Binders, etc. Calcimimetics is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Drugs to Treat Chronic Kidney Disease is widely used in various fields, such as Hospital Pharmacies, Online Pharmacies and Retail Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Drugs to Treat Chronic Kidney Disease industry development. In 2022, global % revenue of Drugs to Treat Chronic Kidney Disease went into Hospital Pharmacies filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Drugs to Treat Chronic Kidney Disease market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Drugs to Treat Chronic Kidney Disease market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer Inc.
Johnson & Johnson
AbbVie Inc.
Bayer AG
Novartis AG
Sanofi SA
Bristol-Myers Squibb Company
AstraZeneca plc
Eli Lilly and Company
C.H. Boehringer Sohn AG & Co. KG
Amgen Inc.
Novo Nordisk A/S
Teva Pharmaceutical Industries Ltd.
Otsuka Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Company Limited
Segment by Type
Calcimimetics
Vitamin D
Sterols
Potassium Binders
Calcium-Based Phosphate Binders

Segment by Application


Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Drugs to Treat Chronic Kidney Disease introduction, etc. Drugs to Treat Chronic Kidney Disease Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Drugs to Treat Chronic Kidney Disease
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Calcimimetics
1.2.3 Vitamin D
1.2.4 Sterols
1.2.5 Potassium Binders
1.2.6 Calcium-Based Phosphate Binders
1.3 Market by Application
1.3.1 Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs to Treat Chronic Kidney Disease Market Perspective (2018-2029)
2.2 Global Drugs to Treat Chronic Kidney Disease Growth Trends by Region
2.2.1 Drugs to Treat Chronic Kidney Disease Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drugs to Treat Chronic Kidney Disease Historic Market Size by Region (2018-2024)
2.2.3 Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Region (2024-2029)
2.3 Drugs to Treat Chronic Kidney Disease Market Dynamics
2.3.1 Drugs to Treat Chronic Kidney Disease Industry Trends
2.3.2 Drugs to Treat Chronic Kidney Disease Market Drivers
2.3.3 Drugs to Treat Chronic Kidney Disease Market Challenges
2.3.4 Drugs to Treat Chronic Kidney Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drugs to Treat Chronic Kidney Disease by Players
3.1.1 Global Drugs to Treat Chronic Kidney Disease Revenue by Players (2018-2024)
3.1.2 Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Players (2018-2024)
3.2 Global Drugs to Treat Chronic Kidney Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drugs to Treat Chronic Kidney Disease, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Drugs to Treat Chronic Kidney Disease Market Concentration Ratio
3.4.1 Global Drugs to Treat Chronic Kidney Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs to Treat Chronic Kidney Disease Revenue in 2022
3.5 Global Key Players of Drugs to Treat Chronic Kidney Disease Head office and Area Served
3.6 Global Key Players of Drugs to Treat Chronic Kidney Disease, Product and Application
3.7 Global Key Players of Drugs to Treat Chronic Kidney Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs to Treat Chronic Kidney Disease Breakdown Data by Type
4.1 Global Drugs to Treat Chronic Kidney Disease Historic Market Size by Type (2018-2024)
4.2 Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Type (2024-2029)
5 Drugs to Treat Chronic Kidney Disease Breakdown Data by Application
5.1 Global Drugs to Treat Chronic Kidney Disease Historic Market Size by Application (2018-2024)
5.2 Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
6.2 North America Drugs to Treat Chronic Kidney Disease Market Size by Type
6.2.1 North America Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2024)
6.2.2 North America Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029)
6.2.3 North America Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
6.3 North America Drugs to Treat Chronic Kidney Disease Market Size by Application
6.3.1 North America Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2024)
6.3.2 North America Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029)
6.3.3 North America Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
6.4 North America Drugs to Treat Chronic Kidney Disease Market Size by Country
6.4.1 North America Drugs to Treat Chronic Kidney Disease Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2024)
6.4.3 North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
7.2 Europe Drugs to Treat Chronic Kidney Disease Market Size by Type
7.2.1 Europe Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2024)
7.2.2 Europe Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029)
7.2.3 Europe Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
7.3 Europe Drugs to Treat Chronic Kidney Disease Market Size by Application
7.3.1 Europe Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2024)
7.3.2 Europe Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029)
7.3.3 Europe Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
7.4 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country
7.4.1 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2024)
7.4.3 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
8.2 China Drugs to Treat Chronic Kidney Disease Market Size by Type
8.2.1 China Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2024)
8.2.2 China Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029)
8.2.3 China Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
8.3 China Drugs to Treat Chronic Kidney Disease Market Size by Application
8.3.1 China Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2024)
8.3.2 China Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029)
8.3.3 China Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
9.2 Asia Drugs to Treat Chronic Kidney Disease Market Size by Type
9.2.1 Asia Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2024)
9.2.2 Asia Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029)
9.2.3 Asia Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
9.3 Asia Drugs to Treat Chronic Kidney Disease Market Size by Application
9.3.1 Asia Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2024)
9.3.2 Asia Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029)
9.3.3 Asia Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
9.4 Asia Drugs to Treat Chronic Kidney Disease Market Size by Region
9.4.1 Asia Drugs to Treat Chronic Kidney Disease Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drugs to Treat Chronic Kidney Disease Market Size by Region (2018-2024)
9.4.3 Asia Drugs to Treat Chronic Kidney Disease Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Drugs to Treat Chronic Kidney Disease Introduction
11.1.4 Pfizer Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.1.5 Pfizer Inc. Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drugs to Treat Chronic Kidney Disease Introduction
11.2.4 Johnson & Johnson Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.2.5 Johnson & Johnson Recent Developments
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Details
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Drugs to Treat Chronic Kidney Disease Introduction
11.3.4 AbbVie Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.3.5 AbbVie Inc. Recent Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Drugs to Treat Chronic Kidney Disease Introduction
11.4.4 Bayer AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.4.5 Bayer AG Recent Developments
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Drugs to Treat Chronic Kidney Disease Introduction
11.5.4 Novartis AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.5.5 Novartis AG Recent Developments
11.6 Sanofi SA
11.6.1 Sanofi SA Company Details
11.6.2 Sanofi SA Business Overview
11.6.3 Sanofi SA Drugs to Treat Chronic Kidney Disease Introduction
11.6.4 Sanofi SA Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.6.5 Sanofi SA Recent Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.7.5 Bristol-Myers Squibb Company Recent Developments
11.8 AstraZeneca plc
11.8.1 AstraZeneca plc Company Details
11.8.2 AstraZeneca plc Business Overview
11.8.3 AstraZeneca plc Drugs to Treat Chronic Kidney Disease Introduction
11.8.4 AstraZeneca plc Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.8.5 AstraZeneca plc Recent Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Introduction
11.9.4 Eli Lilly and Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.9.5 Eli Lilly and Company Recent Developments
11.10 C.H. Boehringer Sohn AG & Co. KG
11.10.1 C.H. Boehringer Sohn AG & Co. KG Company Details
11.10.2 C.H. Boehringer Sohn AG & Co. KG Business Overview
11.10.3 C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Introduction
11.10.4 C.H. Boehringer Sohn AG & Co. KG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.10.5 C.H. Boehringer Sohn AG & Co. KG Recent Developments
11.11 Amgen Inc.
11.11.1 Amgen Inc. Company Details
11.11.2 Amgen Inc. Business Overview
11.11.3 Amgen Inc. Drugs to Treat Chronic Kidney Disease Introduction
11.11.4 Amgen Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.11.5 Amgen Inc. Recent Developments
11.12 Novo Nordisk A/S
11.12.1 Novo Nordisk A/S Company Details
11.12.2 Novo Nordisk A/S Business Overview
11.12.3 Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Introduction
11.12.4 Novo Nordisk A/S Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.12.5 Novo Nordisk A/S Recent Developments
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Company Details
11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.13.3 Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Introduction
11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.14 Otsuka Pharmaceutical Co. Ltd.
11.14.1 Otsuka Pharmaceutical Co. Ltd. Company Details
11.14.2 Otsuka Pharmaceutical Co. Ltd. Business Overview
11.14.3 Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Introduction
11.14.4 Otsuka Pharmaceutical Co. Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.14.5 Otsuka Pharmaceutical Co. Ltd. Recent Developments
11.15 Takeda Pharmaceutical Company Limited
11.15.1 Takeda Pharmaceutical Company Limited Company Details
11.15.2 Takeda Pharmaceutical Company Limited Business Overview
11.15.3 Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Introduction
11.15.4 Takeda Pharmaceutical Company Limited Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
11.15.5 Takeda Pharmaceutical Company Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Calcimimetics
Table 3. Key Players of Vitamin D
Table 4. Key Players of Sterols
Table 5. Key Players of Potassium Binders
Table 6. Key Players of Calcium-Based Phosphate Binders
Table 7. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Drugs to Treat Chronic Kidney Disease Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Drugs to Treat Chronic Kidney Disease Market Share by Region (2018-2024)
Table 11. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Drugs to Treat Chronic Kidney Disease Market Share by Region (2024-2029)
Table 13. Drugs to Treat Chronic Kidney Disease Market Trends
Table 14. Drugs to Treat Chronic Kidney Disease Market Drivers
Table 15. Drugs to Treat Chronic Kidney Disease Market Challenges
Table 16. Drugs to Treat Chronic Kidney Disease Market Restraints
Table 17. Global Drugs to Treat Chronic Kidney Disease Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Drugs to Treat Chronic Kidney Disease Revenue Share by Players (2018-2024)
Table 19. Global Top Drugs to Treat Chronic Kidney Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Chronic Kidney Disease as of 2022)
Table 20. Global Drugs to Treat Chronic Kidney Disease Industry Ranking 2021 VS 2022 VS 2024
Table 21. Global 5 Largest Players Market Share by Drugs to Treat Chronic Kidney Disease Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of Drugs to Treat Chronic Kidney Disease, Headquarters and Area Served
Table 23. Global Key Players of Drugs to Treat Chronic Kidney Disease, Product and Application
Table 24. Global Key Players of Drugs to Treat Chronic Kidney Disease, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Type (2018-2024)
Table 28. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Type (2024-2029)
Table 30. Global Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Drugs to Treat Chronic Kidney Disease Revenue Share by Application (2018-2024)
Table 32. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Drugs to Treat Chronic Kidney Disease Revenue Share by Application (2024-2029)
Table 34. North America Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2024) & (US$ Million)
Table 35. North America Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2024) & (US$ Million)
Table 37. North America Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Drugs to Treat Chronic Kidney Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2024) & (US$ Million)
Table 40. North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2024) & (US$ Million)
Table 42. Europe Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2024) & (US$ Million)
Table 44. Europe Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Drugs to Treat Chronic Kidney Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2024) & (US$ Million)
Table 47. Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2024) & (US$ Million)
Table 49. China Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2024) & (US$ Million)
Table 51. China Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2024) & (US$ Million)
Table 53. Asia Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2024) & (US$ Million)
Table 55. Asia Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Drugs to Treat Chronic Kidney Disease Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Drugs to Treat Chronic Kidney Disease Market Size by Region (2018-2024) & (US$ Million)
Table 58. Asia Drugs to Treat Chronic Kidney Disease Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029) & (US$ Million)
Table 66. Pfizer Inc. Company Details
Table 67. Pfizer Inc. Business Overview
Table 68. Pfizer Inc. Drugs to Treat Chronic Kidney Disease Product
Table 69. Pfizer Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 70. Pfizer Inc. Recent Developments
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Drugs to Treat Chronic Kidney Disease Product
Table 74. Johnson & Johnson Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 75. Johnson & Johnson Recent Developments
Table 76. AbbVie Inc. Company Details
Table 77. AbbVie Inc. Business Overview
Table 78. AbbVie Inc. Drugs to Treat Chronic Kidney Disease Product
Table 79. AbbVie Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 80. AbbVie Inc. Recent Developments
Table 81. Bayer AG Company Details
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Drugs to Treat Chronic Kidney Disease Product
Table 84. Bayer AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 85. Bayer AG Recent Developments
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Drugs to Treat Chronic Kidney Disease Product
Table 89. Novartis AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 90. Novartis AG Recent Developments
Table 91. Sanofi SA Company Details
Table 92. Sanofi SA Business Overview
Table 93. Sanofi SA Drugs to Treat Chronic Kidney Disease Product
Table 94. Sanofi SA Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 95. Sanofi SA Recent Developments
Table 96. Bristol-Myers Squibb Company Company Details
Table 97. Bristol-Myers Squibb Company Business Overview
Table 98. Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Product
Table 99. Bristol-Myers Squibb Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 100. Bristol-Myers Squibb Company Recent Developments
Table 101. AstraZeneca plc Company Details
Table 102. AstraZeneca plc Business Overview
Table 103. AstraZeneca plc Drugs to Treat Chronic Kidney Disease Product
Table 104. AstraZeneca plc Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 105. AstraZeneca plc Recent Developments
Table 106. Eli Lilly and Company Company Details
Table 107. Eli Lilly and Company Business Overview
Table 108. Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Product
Table 109. Eli Lilly and Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 110. Eli Lilly and Company Recent Developments
Table 111. C.H. Boehringer Sohn AG & Co. KG Company Details
Table 112. C.H. Boehringer Sohn AG & Co. KG Business Overview
Table 113. C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Product
Table 114. C.H. Boehringer Sohn AG & Co. KG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 115. C.H. Boehringer Sohn AG & Co. KG Recent Developments
Table 116. Amgen Inc. Company Details
Table 117. Amgen Inc. Business Overview
Table 118. Amgen Inc. Drugs to Treat Chronic Kidney Disease Product
Table 119. Amgen Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 120. Amgen Inc. Recent Developments
Table 121. Novo Nordisk A/S Company Details
Table 122. Novo Nordisk A/S Business Overview
Table 123. Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Product
Table 124. Novo Nordisk A/S Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 125. Novo Nordisk A/S Recent Developments
Table 126. Teva Pharmaceutical Industries Ltd. Company Details
Table 127. Teva Pharmaceutical Industries Ltd. Business Overview
Table 128. Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Product
Table 129. Teva Pharmaceutical Industries Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 130. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 131. Otsuka Pharmaceutical Co. Ltd. Company Details
Table 132. Otsuka Pharmaceutical Co. Ltd. Business Overview
Table 133. Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Product
Table 134. Otsuka Pharmaceutical Co. Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 135. Otsuka Pharmaceutical Co. Ltd. Recent Developments
Table 136. Takeda Pharmaceutical Company Limited Company Details
Table 137. Takeda Pharmaceutical Company Limited Business Overview
Table 138. Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Product
Table 139. Takeda Pharmaceutical Company Limited Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2024) & (US$ Million)
Table 140. Takeda Pharmaceutical Company Limited Recent Developments
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Drugs to Treat Chronic Kidney Disease Market Share by Type: 2022 VS 2029
Figure 3. Calcimimetics Features
Figure 4. Vitamin D Features
Figure 5. Sterols Features
Figure 6. Potassium Binders Features
Figure 7. Calcium-Based Phosphate Binders Features
Figure 8. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Drugs to Treat Chronic Kidney Disease Market Share by Application: 2022 VS 2029
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Drugs to Treat Chronic Kidney Disease Report Years Considered
Figure 14. Global Drugs to Treat Chronic Kidney Disease Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Drugs to Treat Chronic Kidney Disease Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Drugs to Treat Chronic Kidney Disease Market Share by Region: 2022 VS 2029
Figure 17. Global Drugs to Treat Chronic Kidney Disease Market Share by Players in 2022
Figure 18. Global Top Drugs to Treat Chronic Kidney Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Chronic Kidney Disease as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Drugs to Treat Chronic Kidney Disease Revenue in 2022
Figure 20. North America Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
Figure 22. North America Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
Figure 23. North America Drugs to Treat Chronic Kidney Disease Market Share by Country (2018-2029)
Figure 24. United States Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Drugs to Treat Chronic Kidney Disease Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
Figure 28. Europe Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
Figure 29. Europe Drugs to Treat Chronic Kidney Disease Market Share by Country (2018-2029)
Figure 30. Germany Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Drugs to Treat Chronic Kidney Disease Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
Figure 38. China Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
Figure 39. Asia Drugs to Treat Chronic Kidney Disease Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
Figure 41. Asia Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
Figure 42. Asia Drugs to Treat Chronic Kidney Disease Market Share by Region (2018-2029)
Figure 43. Japan Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Share by Country (2018-2029)
Figure 53. Brazil Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Pfizer Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 60. Johnson & Johnson Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 61. AbbVie Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 62. Bayer AG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 63. Novartis AG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 64. Sanofi SA Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 65. Bristol-Myers Squibb Company Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 66. AstraZeneca plc Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 67. Eli Lilly and Company Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 68. C.H. Boehringer Sohn AG & Co. KG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 69. Amgen Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 70. Novo Nordisk A/S Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 71. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 72. Otsuka Pharmaceutical Co. Ltd. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 73. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed